Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, the Netherlands.
Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, the Netherlands.
N Biotechnol. 2024 Mar 25;79:71-81. doi: 10.1016/j.nbt.2023.12.009. Epub 2023 Dec 27.
The Gram-positive bacterium Bacillus subtilis is a prolific producer of industrial enzymes that are effectively harvested from the fermentation broth. However, the high capacity of B. subtilis for protein secretion has so far not been exploited to the full due to particular bottlenecks, including product degradation by extracellular proteases and counterproductive secretion stress responses. To unlock the Bacillus secretion pathway for difficult-to-produce proteins, various cellular interventions have been explored, including genome engineering. Our previous research has shown a superior performance of genome-reduced B. subtilis strains in the production of staphylococcal antigens compared to the parental strain 168. This was attributed, at least in part, to redirected secretion stress responses, including the presentation of elevated levels of the quality control proteases HtrA and HtrB that also catalyse protein folding. Here we show that this relates to the elimination of two homologous serine proteases, namely the cytosolic protease AprX and the extracellular protease AprE. This unprecedented posttranslational regulation of secretion stress effectors, like HtrA and HtrB, by the concerted action of cytosolic and extracellular proteases has important implications for the biotechnological application of microbial cell factories. In B. subtilis, this conclusion is underscored by extracellular degradation of the staphylococcal antigen IsaA by both AprX and AprE. Extracellular activity of the cytosolic protease AprX is remarkable since it shows that not only extracellular, but also intracellular proteases impact extracellular product levels. We therefore conclude that intracellular proteases represent new targets for improved recombinant protein production in microbial cell factories like B. subtilis.
革兰氏阳性细菌枯草芽孢杆菌是工业酶的丰富生产者,这些酶可以有效地从发酵液中收获。然而,由于特定的瓶颈,枯草芽孢杆菌的高蛋白质分泌能力迄今为止尚未得到充分利用,这些瓶颈包括细胞外蛋白酶对产物的降解和适得其反的分泌应激反应。为了解锁枯草芽孢杆菌分泌途径,以生产难以生产的蛋白质,已经探索了各种细胞干预措施,包括基因组工程。我们之前的研究表明,与亲本菌株 168 相比,基因组减少的枯草芽孢杆菌菌株在葡萄球菌抗原的生产中表现出更好的性能。这至少部分归因于重定向的分泌应激反应,包括呈现出更高水平的质量控制蛋白酶 HtrA 和 HtrB,它们也催化蛋白质折叠。在这里,我们表明这与两种同源丝氨酸蛋白酶 AprX 和 AprE 的消除有关。这种细胞溶质和细胞外蛋白酶协同作用对分泌应激效应物(如 HtrA 和 HtrB)的前所未有的翻译后调控,对微生物细胞工厂的生物技术应用具有重要意义。在枯草芽孢杆菌中,这种结论得到了 AprX 和 AprE 对葡萄球菌抗原 IsaA 的细胞外降解的支持。细胞溶质蛋白酶 AprX 的细胞外活性非常显著,因为它表明不仅细胞外,而且细胞内蛋白酶也会影响细胞外产物水平。因此,我们得出结论,细胞内蛋白酶代表了微生物细胞工厂(如枯草芽孢杆菌)中改进重组蛋白生产的新目标。